Clinical Trials Browser

Phase 2 × Breast Cancer Prevention × Metformin × Clear all

NCT02028221 2023-06-27

Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk

Phase 2 Completed

151 enrolled 15 charts

Breast Cancer Prevention